根據最新的財務報表(Form-10K),Cosmos Health Inc 的總資產為 $0,淨損失為 $0
COSM 的關鍵財務比率是什麼?
Cosmos Health Inc 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Cosmos Health Inc 的收入按細分市場或地理位置如何劃分?
Cosmos Health Inc 最大收入來源為 Wholesale,在最近的收益報告中收入為 51,593,787。就地區而言,Greece 是 Cosmos Health Inc 的主要市場,收入為 52,935,979。
Cosmos Health Inc 是否盈利?
無,根據最新的財務報表,Cosmos Health Inc 的淨損失為 $0
Cosmos Health Inc 有負債嗎?
無,Cosmos Health Inc 的負債為 0
Cosmos Health Inc 的流通股有多少?
Cosmos Health Inc 的總流通股為 0
關鍵數據
前收市價
$0.3069
開盤價
$0.308
當日範圍
$0.297 - $0.3336
52週區間
$0.2801 - $1.32
交易量
1.1M
平均成交量
917.5K
股息收益率
--
每股盈餘 (TTM)
-0.71
市值
$11.8M
什麼是 COSM?
Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The firm owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.